⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ACXP News
Acurx Pharmaceuticals, Inc. Common Stock
Acurx Pharmaceuticals, Inc. Announces up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
prnewswire.com
ACXP
New to The Street Broadcasts on Bloomberg Television at 6:30 PM EST Featuring IGC Pharma (IGC), Vivos Therapeutics (VVOS), Acurx Pharmaceuticals (ACXP), and Equinox Gold (EQX)
accessnewswire.com
IGC
VVOS
ACXP
EQX
DVLT
CISO
VTIX
NRXP
New to The Street Resigns Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) to Continue Long-Form Interview Series, Outdoor Media Campaigns and Accredited Investor Events
accessnewswire.com
ACXP
New to The Street Announces Episode 741 Airing Tonight on Bloomberg Television at 6:30 PM EST Featuring Canton Networks, Acme Markets, Virtuix Holdings (VTIX), HPB, Jonas & Redman, Acurx Pharmaceuticals (ACXP), and FreeCast (CAST)
accessnewswire.com
ACXP
VTIX
CAST
Korean Patent Office Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors
prnewswire.com
ACXP
New to The Street Broadcasts Show #740 on Bloomberg Television at 6:30 PM EST Featuring Medicus (MDCX), Acme Markets- Canton Foundation, Alpha Ton Capital (ATON), and Virtuix Holdings (NASDAQ:VTIX)
accessnewswire.com
ACXP
DVLT
IGC
NRXP
SNYR
TRN
VTIX
VVOS
YYGH
MDCX
ATON
Acurx Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter Results and Provides Business Update
prnewswire.com
ACXP
Form 8-K
sec.gov
ACXP
Approximately 20 million pets in the U.S. experience poverty with their families
prnewswire.com
ACXP
Acurx Announces New Ibezapolstat Clinical Trial Program in Patients with Recurrent CDI That Has the Potential to Shift the Paradigm of Treatment and Prevention of C. difficile Infection
prnewswire.com
ACXP